SEC Form 4 · accession 0001144204-17-047743
PHIBRO ANIMAL HEALTH CORP · PAHC
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Larry Lee Miller
Officer — Chief Operating Officer
Period of report
Sep 8, 2017
Accepted (ET)
Sep 12, 2017 · 9:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001069899
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Class A Common Stock | Sep 8, 2017 | M | 14,930 | $11.83 | A | 14,930 | D | |
| Class A Common StockF2 | Sep 8, 2017 | S | 14,930 | $36.19 | D | 0 | D | |
| Class A Common Stock | Sep 11, 2017 | M | 9,700 | $11.83 | A | 9,700 | D | |
| Class A Common StockF3 | Sep 11, 2017 | S | 9,700 | $36.26 | D | 0 | D | |
| Class A Common Stock | Sep 12, 2017 | M | 21,472 | $11.83 | A | 21,472 | D | |
| Class A Common StockF4 | Sep 12, 2017 | S | 21,472 | $36.45 | D | 0 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Option to purchase Common StockF5 | $11.83 | Sep 8, 2017 | M | 14,930 | D | Mar 1, 2012 | Feb 28, 2019 | Class A Common Stock | 14,930 | 125,111 | D |
| Option to purchase Common StockF5 | $11.83 | Sep 11, 2017 | M | 9,700 | D | Mar 1, 2012 | Feb 28, 2019 | Class A Common Stock | 9,700 | 115,411 | D |
| Option to purchase Common StockF5 | $11.83 | Sep 12, 2017 | M | 21,472 | D | Mar 1, 2012 | Feb 28, 2019 | Class A Common Stock | 21,472 | 93,939 | D |
Explanation of responses
- F1The sales reported in the Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on June 14, 2016.
- F2The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.00 to $36.65, inclusive.
- F3The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.20 to $36.40, inclusive.
- F4The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $36.20 to $36.65, inclusive.
- F5The date exercisable for the securities included on this line was previously incorrectly reported. The information in this column reflects the correct date exercisable for Mr. Miller's options to purchase Class A Common Stock.